Alison Cecily Finger

Chief Commercial Officer, bluebird bio.

Companies

ADMA Biologics (United States)Board member Oct 2, 2023 to now¹
Decibel Therapeutics, Inc.Board member Dec 6, 2021 to Sep 25, 2023²
bluebird bioChief Commercial Officer Feb 20, 2018 to Jan 8, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ADMA Biologics (United States) ADMA45,619 shares⁴$505.7K at $11.09Feb 9, 2026
Decibel Therapeutics, Inc.0 shares⁵Sep 25, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 9, 2026Granted 10,690 shares of ADMA Biologics (United States)⁴
Feb 19, 2025Granted 10,889 shares of ADMA Biologics (United States)⁶
Feb 26, 2024Granted 24,040 shares of ADMA Biologics (United States)⁷
Sep 25, 2023Returned to company 5,000 shares of Decibel Therapeutics, Inc.⁵
Jun 13, 2023Granted 5,000 shares of Decibel Therapeutics, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARADMA Biologics (United States), Board member
2
SEC EDGARDecibel Therapeutics, Inc., Board member
3
SEC EDGARbluebird bio, Chief Commercial Officer
4
SEC EDGARADMA Biologics (United States) shares after the filing of Feb 9, 2026
5
SEC EDGARDecibel Therapeutics, Inc. shares after the filing of Sep 25, 2023
6
SEC EDGARForm 4 filed Feb 21, 2025
7
SEC EDGARForm 4 filed Feb 28, 2024
8
SEC EDGARForm 4 filed Jun 14, 2023